Outer Membrane Vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells
Tomasi, M.; Caproni, E.; Benedet, M.; Zanella, I.; Giorgetta, S.; Dalsass, M.; Koenig, E.; Gagliardi, A.; Fantappie', L.; Berti, A.; Tamburini, S.; Croia, L.; Di Lascio, G.; Bellini, E.; Valensin, S.; Licata, G.; Sebastiani, G.; Dotta, F.; Armanini, F.; Cumbo, F.; Asnicar, F.; Blanco-Miguez, A.; Ruggiero, E.; Segata, N.; Grandi, A.; Grandi, G.
Show abstract
The gut microbiome plays a key role in cancer immunity. One proposed mechanism is through the elicitation of T cells, which incidentally recognize neo-epitopes arising from cancer mutations ("molecular mimicry (MM)" hypothesis). To support MM, Escherichia coli Nissle was engineered with the SIINFEKL epitope (OVA) and orally administered to C57BL/6 mice. The treatment elicited OVA-specific CD8+ T cells in the lamina propria and inhibited the growth of OVA-B16F10 tumors. Importantly, the administration of Outer Membrane Vesicles (OMVs) engineered with different T cell epitopes elicited epitope-specific T cells and inhibited tumor growth. Microbiome shotgun sequencing and TCR sequencing provided evidence that cross-reacting T cells were induced at the mucosal level and subsequently reached the tumor site. Overall, our data support the role of MM in tumor immunity, assign a new role to OMVs and pave the way to new probiotics/OMV-based anti-cancer immunotherapies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Overcoming the nutritional immunity by engineering iron scavenging bacteria for cancer therapy 95%
- Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy 94%
- Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the immunoreceptor CD300a 94%
Similar papers in this journal
- Gut microbiota transplantation drives the adoptive transfer of colonic genotype-phenotype characteristics between mice lacking catestatin and their wild type counterparts 94%
- A history of repeated antibiotic usage leads to microbiota-dependent mucus defects 94%
- Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine 93%
Similar papers in this journal
- Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity 93%
- Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2 93%
- The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory 93%
Similar papers in this journal
- A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta 94%
- Inulin prebiotic reinforces host cancer immunosurveillance via γδ T cell activation 94%
- IL-7-adjuvanted vaginal vaccine elicits strong mucosal immune responses in non-human primates 93%
Similar papers in this journal
- Gut microbiota dysbiosis induced by brain tumor modulates the efficacy of immunotherapy 95%
- Differential translocation of bacteriophages across the intestinal barrier in health and Crohn's disease 93%
- Mucosal innate immune activation as the trigger to Prevotella species-induced arthritis in genetically resistant mice 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.